We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Nephrology

Nephrology

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Evaluating Renal Resistive Index Responsiveness to MAP Targets in Early Septic Shock: Clinical Implications and Physiologic Insights
Critical Careseptic shockmean arterial pressure

Evaluating Renal Resistive Index Responsiveness to MAP Targets in Early Septic Shock: Clinical Implications and Physiologic Insights

By MedXY|Aug 5, 2026

This study explores whether renal resistive index (RRI) changes during a transient elevation of mean arterial pressure (MAP) can guide individualized MAP targets to optimize renal function in early septic shock, finding that RRI decrease do

End-Organ Damage in Primary Hyperparathyroidism: Prevalence, Progression, and Treatment Gaps in a National Cohort
Diabetes & EndocrinologyPrimary hyperparathyroidismosteoporosis

End-Organ Damage in Primary Hyperparathyroidism: Prevalence, Progression, and Treatment Gaps in a National Cohort

By MedXY|Aug 4, 2026

A nationwide cohort study reveals that two-thirds of patients with primary hyperparathyroidism exhibit end-organ damage at diagnosis or during follow-up, yet few receive parathyroidectomy, underscoring missed opportunities to reduce morbidi

Balancing Blood Pressure After Endovascular Thrombectomy: Risks of Acute Kidney Injury and Impact on Stroke Recovery
Nephrologyischemic strokeEndovascular Thrombectomy

Balancing Blood Pressure After Endovascular Thrombectomy: Risks of Acute Kidney Injury and Impact on Stroke Recovery

By MedXY|Aug 4, 2026

Intensive blood pressure lowering post-thrombectomy increases acute kidney injury risk, which correlates with poorer neurological outcomes in stroke patients. Careful BP management is crucial to prevent renal complications and optimize reco

STARDaki: Standardizing How We Report Acute Kidney Injury Biomarker Studies
Critical CareAKIbiomarkers

STARDaki: Standardizing How We Report Acute Kidney Injury Biomarker Studies

By MedXY|Jul 30, 2026

An expert consensus (STARDaki) extends STARD to improve reporting of diagnostic test accuracy studies for acute kidney injury (AKI), specifying patient selection, reference standards, timing, assay details and test-retest reliability.

Machine-learning model incorporating perioperative hemodynamics predicts moderate-to-severe AKI after heart transplantation
TransplantationHeart Transplantationacute kidney injury

Machine-learning model incorporating perioperative hemodynamics predicts moderate-to-severe AKI after heart transplantation

By MedXY|Jul 29, 2026

A machine-learning model using perioperative hemodynamic indices accurately predicted stage 2-3 acute kidney injury after orthotopic heart transplantation in 114 patients, with light gradient boosting machine achieving AUC 0.898.

Early Rhythm Control Reduces Cardiovascular Events in Atrial Fibrillation Patients With Chronic Kidney Disease
Cardiologyatrial fibrillationchronic kidney disease

Early Rhythm Control Reduces Cardiovascular Events in Atrial Fibrillation Patients With Chronic Kidney Disease

By MedXY|Jul 28, 2026

A predefined subanalysis of EAST-AFNET 4 shows early rhythm control safely reduces cardiovascular events in recently diagnosed AF patients with CKD, with a trend toward greater benefit in this high-risk group.

Home Dialysis Underuse: Historical Policy Barriers and Enduring Disparities
Internal Medicinehome dialysis卫生政策

Home Dialysis Underuse: Historical Policy Barriers and Enduring Disparities

By MedXY|Jul 27, 2026

A historical analysis reveals that policy decisions, financial incentives, and for-profit dialysis centers have contributed to persistent underuse of home dialysis in the US, especially among marginalized populations.

IgG N-Glycosylation Profiles as Predictive Biomarkers for Diabetic Nephropathy in Type 2 Diabetes: Insights from a Pooled Prospective Cohort Analysis
Diabetes & EndocrinologyDiabetic Nephropathydiabetic neuropathy

IgG N-Glycosylation Profiles as Predictive Biomarkers for Diabetic Nephropathy in Type 2 Diabetes: Insights from a Pooled Prospective Cohort Analysis

By MedXY|Jul 19, 2026

A pooled analysis of four cohorts reveals that specific IgG N-glycosylation patterns are significantly associated with incident diabetic nephropathy, highlighting immune-related mechanisms in disease progression.

Expanding the Horizon of Simultaneous Liver-Kidney Transplantation: Leveraging DCD Donors with Machine Perfusion Technologies
General Surgerydonation after circulatory deathMachine Perfusion

Expanding the Horizon of Simultaneous Liver-Kidney Transplantation: Leveraging DCD Donors with Machine Perfusion Technologies

By MedXY|Jul 8, 2026

This nationwide US study analyzes 10,687 simultaneous liver-kidney transplants, highlighting increased use of DCD donors with machine perfusion and comparable outcomes to DBD transplants, supporting broader DCD adoption in selected patients

Acoramidis and Kidney Function in Transthyretin Amyloid Cardiomyopathy: Clinical Implications and Hemodynamic Insights
Cardiologyacoramidisalbuminuria

Acoramidis and Kidney Function in Transthyretin Amyloid Cardiomyopathy: Clinical Implications and Hemodynamic Insights

By MedXY|Jul 3, 2026

Acoramidis stabilizes transthyretin and shows kidney-protective effects in transthyretin amyloid cardiomyopathy by reducing eGFR decline and albuminuria, with an initial reversible dip in kidney function associated with improved clinical ou

Continuous Glucose Monitoring and Survival Benefits in Diabetic Veterans on Dialysis: Insights from a Nationwide Cohort
Diabetes & Endocrinologycontinuous glucose monitoringdiabetes

Continuous Glucose Monitoring and Survival Benefits in Diabetic Veterans on Dialysis: Insights from a Nationwide Cohort

By MedXY|Jul 1, 2026

Among U.S. veterans with diabetes on dialysis, continuous glucose monitoring (CGM) use was associated with significantly lower mortality risk compared to non-CGM use, highlighting CGM’s potential to improve survival in this high-risk

The Impact of APOL1 Genotype on Kidney Function After Living Donation in Black Donors
Internal MedicineAPOL1 genotypeBlack donors

The Impact of APOL1 Genotype on Kidney Function After Living Donation in Black Donors

By MedXY|Jun 30, 2026

APOL1 high-risk genotypes significantly increase the risk of reduced kidney function after living kidney donation in Black donors, highlighting the need for genotype screening to improve donor risk stratification.

Thyroid Hormones May Offer a New Therapeutic and Prognostic Angle in ADPKD
Diabetes & EndocrinologyADPKDbiomarker

Thyroid Hormones May Offer a New Therapeutic and Prognostic Angle in ADPKD

By MedXY|Jun 19, 2026

Thyroid hormone signaling may influence ADPKD progression, with preclinical cyst suppression and patient biomarker associations suggesting prognostic and therapeutic potential.

Finerenone May Lower Sudden Death Risk Across the Cardio-Kidney-Metabolic Continuum
Cardiologycardio-kidney-metabolic syndromechết đột ngột

Finerenone May Lower Sudden Death Risk Across the Cardio-Kidney-Metabolic Continuum

By MedXY|Jun 9, 2026

A prespecified pooled analysis of 18,991 participants found finerenone was associated with a significant reduction in sudden death across chronic kidney disease, type 2 diabetes, and heart failure populations.

Chronic Kidney Disease Worsens Short-Term Outcomes in Hospitalized Patients With Cirrhosis Across a Global Cohort
Gastroenterologyacute kidney injurychronic kidney disease

Chronic Kidney Disease Worsens Short-Term Outcomes in Hospitalized Patients With Cirrhosis Across a Global Cohort

By MedXY|Jun 7, 2026

In a large international prospective cohort of hospitalized patients with cirrhosis, chronic kidney disease was common, clustered with metabolic risk, and strongly associated with acute kidney injury, more decompensation, and higher in-hosp

Finerenone Shows Consistent Cardiovascular and Kidney Benefit Across CKM Syndrome Stages in Type 2 Diabetes and CKD
Cardiologychronic kidney diseasefinerenone

Finerenone Shows Consistent Cardiovascular and Kidney Benefit Across CKM Syndrome Stages in Type 2 Diabetes and CKD

By MedXY|Jun 7, 2026

A post hoc FIDELITY analysis suggests finerenone improves cardiovascular and kidney outcomes across CKM stages and may modestly shift patients toward CKM regression over time.

SLA-DR–Deleted Donor Pigs Show Durable Kidney Xenograft Function and a Favorable Safety Profile in Rhesus Monkeys
General Surgerykidney transplantrhesus monkey

SLA-DR–Deleted Donor Pigs Show Durable Kidney Xenograft Function and a Favorable Safety Profile in Rhesus Monkeys

By MedXY|Jun 6, 2026

CRISPR-engineered GGTA1/B4GALNT2/SLA-DR knockout pigs remained healthy, screened negative for 55 zoonotic pathogens, and supported long-term renal xenograft function in rhesus monkeys when preformed anti-SLA antibodies were absent.

Impact of Normothermic Regional Perfusion on Outcomes in Kidney Transplantation From Donors After Circulatory Death
NephrologyDCDdelayed graft function

Impact of Normothermic Regional Perfusion on Outcomes in Kidney Transplantation From Donors After Circulatory Death

By MedXY|Jun 4, 2026

In a nationwide U.S. analysis of 21,010 adult DCD kidney transplants, normothermic regional perfusion lowered delayed graft function, shortened hospital stay, and improved graft and patient survival, with the greatest benefit in higher-risk

Proteinuria in Preeclampsia and Long-Term Risk of Maternal Kidney and Cardiovascular Disease
Nephrologycardiovascular diseasePregnancy

Proteinuria in Preeclampsia and Long-Term Risk of Maternal Kidney and Cardiovascular Disease

By MedXY|Aug 18, 2026

Higher proteinuria in preeclampsia was linked to greater long-term risk of maternal hypertension and chronic kidney disease, with overall increased risk of cardiovascular disease as well.

Tirzepatide vs dulaglutide: kidney outcomes in type 2 diabetes from SURPASS-CVOT
Diabetes & Endocrinologyalbuminuriachronic kidney disease

Tirzepatide vs dulaglutide: kidney outcomes in type 2 diabetes from SURPASS-CVOT

By MedXY|May 12, 2026

In a pre-specified exploratory analysis of SURPASS-CVOT, tirzepatide reduced major kidney events versus dulaglutide in people with type 2 diabetes and cardiovascular disease, mainly by lowering new macroalbuminuria and slowing eGFR decline.

Prev
2 / 9
1234…9
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles